Background In November 2017, the Food and Drug Administration (FDA) approved a version of a second-generation antipsychotic, aripiprazole, embedded with a sensor (Abilify MyCite). Objective To ...

See why Teva Pharmaceutical Industries Limited is shifting the CNS market with Austedo sales growth, new clinical data, and falling debt. Click for my TEVA update.

A neuroimaging study conducted in the United Kingdom found that taking the antipsychotic amisulpride (400 mg/day) for one week increased the volume of the left putamen and right caudate regions of the ...

Abilify (aripiprazole) is a prescription atypical antipsychotic that treats depression, schizophrenia, bipolar disorder, irritability related to autism, and specific Tourette's symptoms. While most ...

Aripirazole is an antipsychotic drug - a type of medication used to treat serious mental disorders such as paranoia. It has also been used to treat behavioural problems (e.g. aggression, severe temper ...

Overall, 3,620 US patients were identified: 2,870 treated with goserelin 3.6 mg once every 4 weeks, 410 treated with 10.8 mg once every 12 weeks, and 340 switched from 3.6 mg once every 4 weeks to ...

Abilify is not a controlled substance. It’s an atypical antipsychotic drug. Abilify has some high risk side effects. It also carries boxed warnings, the most serious warnings from the Food and Drug ...

Aristada (aripiprazole lauroxil) is a prescription drug that’s used to treat schizophrenia. Aristada is given by a healthcare professional as an injection into a muscle. Aristada is used as a ...

State Key Laboratory of Chemical Engineering, School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, China The National Engineering Research Center of Industrial ...

Once-monthly aripiprazole was more effective in achieving symptomatic and well-being remission, as opposed to functional remission. Among adult outpatients with schizophrenia, aripiprazole ...